Area: |
School of Biomedical Sciences | ||||||||||||||||||||||||
Credits: |
25.0 | ||||||||||||||||||||||||
Contact Hours: |
7.0 | ||||||||||||||||||||||||
** The tuition pattern below provides details of the types of classes and their duration. This is to be used as a guide only. For more precise information please check your unit outline. ** | |||||||||||||||||||||||||
Lecture: |
1 x 3 Hours Weekly | ||||||||||||||||||||||||
Laboratory: |
1 x 4 Hours Weekly | ||||||||||||||||||||||||
Prerequisite(s): |
8054 (v.9) Clinical Biochemistry 232 or any previous version AND 302426 (v.2) Histopathology 232 or any previous version AND 302431 (v.1) Haematology 232 or any previous version AND 302436 (v.2) Immunobiology 232 or any previous version AND 302477 (v.2) Clinical Microbiology 232 or any previous version |
||||||||||||||||||||||||
Syllabus: |
This unit covers the biochemical investigation of abnormalities in electrolyte, carbohydrate, cholesterol, calcium, haem, and porphyrin metabolism; biochemical markers of cardiac, pancreatic and liver function and/or damage. In the specific context of analytical techniques, lectures and practicals cover quality control, use of radio-isotopes, and the physico-chemical principles underlying clinical biochemistry tests/techniques such as chromatography, enzymology, electrophoresis, fluorimetry, nephelometry and turbidimetry, and ligand binding assays (for example, immuno and receptor assays). | ||||||||||||||||||||||||
** To ensure that the most up-to-date information about unit references, texts and outcomes appears, they will be provided in your unit outline prior to commencement. ** | |||||||||||||||||||||||||
Field of Education: | 010913 Human Biology | ||||||||||||||||||||||||
Funding Cluster: | 08 - Engineering, Science, Surveying | ||||||||||||||||||||||||
SOLT (Online) Definitions*: | Supplemental *Extent to which this unit or thesis utilises online information | ||||||||||||||||||||||||
Result Type: | Grade/Mark | ||||||||||||||||||||||||
Availability |
|||||||||||||||||||||||||
|